Glaukos (GKOS) Income from Continuing Operations (2014 - 2026)
Glaukos (GKOS) reported Income from Continuing Operations of 19783000.0 for Q1 2026, down 9.18% year-over-year from 21782096.37 in Q1 2025, and down 130.92% quarter-over-quarter from 63979000.0 in Q4 2025.
Glaukos (GKOS) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Income from Continuing Operations data on file, last reported at 19783000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 19783000.0, down 9.18% year-over-year; the trailing twelve-month figure through Mar 2026 was 8308000.0 (down 65.34% YoY), and the FY2025 annual result was 9945000.0, up 702.02% from the prior year.
- Income from Continuing Operations slipped to 19783000.0 in Q1 2026 per GKOS's latest filing, from 63979000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 114047000.0 in Q4 2024 and troughed at 50545000.0 in Q2 2024.
- A 5-year average of 170823.53 and a median of 19783000.0 in 2026 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations surged 391.37% in 2022, then plunged 740.87% in 2023.
- A 5-year view of Income from Continuing Operations shows it stood at 69856000.0 in 2022, then jumped by 45.02% to 101306000.0 in 2023, then increased by 12.58% to 114047000.0 in 2024, then tumbled by 43.9% to 63979000.0 in 2025, then sank by 130.92% to 19783000.0 in 2026.
- Business Quant data shows GKOS's Income from Continuing Operations at 19783000.0 in Q1 2026, 63979000.0 in Q4 2025, and 16231000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Glaukos | 7.55 Bn | 7.45 Bn | 117.23 Mn | -19.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.78 Mn |
| Dec 31, 2025 | 63.98 Mn |
| Sep 30, 2025 | -16.23 Mn |
| Jun 30, 2025 | -19.66 Mn |
| Mar 31, 2025 | -18.12 Mn |
| Dec 31, 2024 | 114.05 Mn |
| Sep 30, 2024 | -21.41 Mn |
| Jun 30, 2024 | -50.55 Mn |
| Mar 31, 2024 | -40.84 Mn |
| Dec 31, 2023 | 101.31 Mn |
| Sep 30, 2023 | -30.44 Mn |
| Jun 30, 2023 | -32.78 Mn |
| Mar 31, 2023 | -34.63 Mn |
| Dec 31, 2022 | 69.86 Mn |
| Sep 30, 2022 | -27.53 Mn |
| Jun 30, 2022 | -45.54 Mn |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | -23.98 Mn |
| Sep 30, 2021 | 6.23 Mn |
| Jun 30, 2021 | -17.48 Mn |